Table 2 The detail compliance of IC and concurrent chemotherapy between two arms.

From: Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin

 

TPF regimen

GP regimen

P value

Induction chemotherapy

Total No. of cycles given, %

  

0.53

 Two cycles

11 (19.0%)

8 (14.5%)

 

 Three cycles

47 (81.0%)

47 (85.5%)

 

Concurrent chemotherapy

Total No. of cycles given, %

  

0.82

 One cycles

4 (6.9%)

3 (5.4%)

 

 Two cycles

7 (12.1%)

5 (9.1%)

 

 Three cycles

47 (81.0%)

47 (85.5%)

 
Back to article page